< Back to previous page
Researcher
Paul Meyvisch
- Disciplines:Applied mathematics in specific fields, Statistics and numerical methods, Scientific computing, Bioinformatics and computational biology, Public health care, Public health services
Affiliations
- Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat) (Division)
Member
From17 Jul 2018 → 19 Mar 2021
Publications
1 - 10 of 10
- Surrogate Marker evaluation in clinical trials using methods of causal inference(2020)
Authors: Paul Meyvisch, Ariel Alonso Abad, Geert Molenberghs
- On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomes(2020)
Authors: Paul Meyvisch, Ariel Alonso Abad, Geert Molenberghs
Pages: 3867 - 3878 - Optimizing sample size in relative bioavailability trials using a Bayesian decision-theoretic framework(2020)
Authors: Paul Meyvisch
Pages: 167 - 175 - Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design(2019)
Authors: Paul Meyvisch, Wim Wuyts
Pages: 3059 - 3070 - Univariate Versus Multivariate Surrogates in the Single-Trial Setting(2019)
Authors: Ariel Alonso Abad, Paul Meyvisch, Geert Molenberghs
Pages: 301 - 310 - A reflection on the possibility of finding a good surrogate(2019)
Authors: Ariel Alonso Abad, Paul Meyvisch, Geert Molenberghs, Geert Verbeke
Pages: 468 - 477 - Assessing the predictive value of a binary surrogate for a binary true endpoint based on the minimum probability of a prediction error(2019)
Authors: Paul Meyvisch, Ariel Alonso Abad, Geert Molenberghs
Pages: 304 - 315 - Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial(2018)
Authors: Paul Meyvisch, Ariel Alonso Abad
Pages: 1 - 15 - Assessing a surrogate predictive value: a causal inference approach(2017)
Authors: Ariel Alonso Abad, Wim Van der Elst, Paul Meyvisch
Pages: 1083 - 1098 - Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir in treatment-naive HIV-1-infected patients(2014)
Authors: Carla Truyers, Paul Meyvisch
Pages: 283 - 289